These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3167806)
1. Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer. Yamanaka N; Himi T; Harabuchi Y; Hoki K; Kataura A Cancer; 1988 Nov; 62(9):1932-8. PubMed ID: 3167806 [TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG). Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736 [TBL] [Abstract][Full Text] [Related]
3. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma. Yasumatsu R; Nakano T; Hashimoto K; Kogo R; Wakasaki T; Nakagawa T Auris Nasus Larynx; 2019 Feb; 46(1):135-140. PubMed ID: 30078551 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen]. Arlt A; Luckhaupt H; Hildmann H Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684 [TBL] [Abstract][Full Text] [Related]
5. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC]. Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935 [TBL] [Abstract][Full Text] [Related]
6. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Eibling DE; Johnson JT; Wagner RL; Su S Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421 [TBL] [Abstract][Full Text] [Related]
7. Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer. Holdenrieder S; Molina R; Qiu L; Zhi X; Rutz S; Engel C; Kasper-Sauer P; Dayyani F; Korse CM Tumour Biol; 2018 Apr; 40(4):1010428318772202. PubMed ID: 29701125 [TBL] [Abstract][Full Text] [Related]
8. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer. Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943 [TBL] [Abstract][Full Text] [Related]
9. Serum SCC-Ag in head and neck squamous cell carcinoma. Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas]. Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163 [TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck]. Zöller J; Fiehn W; Mende U; Hotz G Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649 [TBL] [Abstract][Full Text] [Related]
13. [Squamous cell carcinoma-associated antigen (SCC) as a tumor marker in the initial diagnosis of carcinomas of the head and neck region. Results of a prospective study after 24 months]. Clasen B; Péré P; Senekowitsch R; Menz E Laryngorhinootologie; 1990 May; 69(5):275-80. PubMed ID: 2191678 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of serum squamous cell carcinoma-related antigen levels in patients with malignant neoplasms]. Jinnouchi S; Hoshi H; Mori Y; Harada K; Onoe K; Nagamachi S; Futami S; Ebihara H; Watanabe K; Tahara Y Radioisotopes; 1986 Dec; 35(12):642-4. PubMed ID: 3823498 [No Abstract] [Full Text] [Related]
15. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Mino N; Iio A; Hamamoto K Cancer; 1988 Aug; 62(4):730-4. PubMed ID: 2840187 [TBL] [Abstract][Full Text] [Related]
16. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia. Piotti KC; Scognamiglio T; Chiu R; Chen YT Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616 [TBL] [Abstract][Full Text] [Related]
17. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months]. Clasen B; Roettger D; Senekowitsch R; Menz E Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877 [TBL] [Abstract][Full Text] [Related]
18. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm]. Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455 [TBL] [Abstract][Full Text] [Related]
19. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093 [TBL] [Abstract][Full Text] [Related]
20. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck]. Koch T; Eiffert H; Spindler MB HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]